Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Govoni

Showing results (141-150 of 254) with videos related to

Pageof 26
Sort By:
Arthritis Care & Research|July 24, 2020
Impact of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Multicenter Cohort Study of 133 Women With Undifferentiated Connective Tissue DiseaseMassimo Radin, Karen Schreiber, Irene Cecchi, et al.
Rheumatology (Oxford, England)|January 17, 2020
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolutionMassimo Radin, Karen Schreiber, Irene Cecchi, et al.
RMD Open|July 25, 2020
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI)Matteo Piga, Alberto Floris, Gerard Espinosa, et al.
Clinical Rheumatology|July 16, 2016
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function abilityFlorenzo Iannone, Lugi Sinigaglia, Ennio Giulio Favalli, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registriesVeronica Codullo, Florenzo Iannone, Luigi Sinigaglia, et al.
Minerva Medica|February 8, 2021
Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE studyTeodora Serban, Roberto Allara, Valeria Azzolini, et al.
Autoimmunity Reviews|October 27, 2010
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritisMartina Fabris, Luca Quartuccio, Sandra Lombardi, et al.
Rheumatology (Oxford, England)|December 17, 2019
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohortMatteo Piga, Alberto Floris, Gian Domenico Sebastiani, et al.
Clinical and Experimental Rheumatology|January 31, 2017
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based studyOlga Addimanda, Massimiliano Marino, Ilaria Farina, et al.
RMD Open|December 29, 2022
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational studyAlberto Floris, Elisabetta Chessa, Gian Domenico Sebastiani, et al.
Pageof 26

Showing results (141-150 of 254) with videos related to

Sort By:
Pageof 26
Arthritis Care & Research|July 24, 2020
Impact of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Multicenter Cohort Study of 133 Women With Undifferentiated Connective Tissue DiseaseMassimo Radin, Karen Schreiber, Irene Cecchi, et al.
Rheumatology (Oxford, England)|January 17, 2020
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolutionMassimo Radin, Karen Schreiber, Irene Cecchi, et al.
RMD Open|July 25, 2020
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI)Matteo Piga, Alberto Floris, Gerard Espinosa, et al.
Clinical Rheumatology|July 16, 2016
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function abilityFlorenzo Iannone, Lugi Sinigaglia, Ennio Giulio Favalli, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registriesVeronica Codullo, Florenzo Iannone, Luigi Sinigaglia, et al.
Minerva Medica|February 8, 2021
Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE studyTeodora Serban, Roberto Allara, Valeria Azzolini, et al.
Autoimmunity Reviews|October 27, 2010
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritisMartina Fabris, Luca Quartuccio, Sandra Lombardi, et al.
Rheumatology (Oxford, England)|December 17, 2019
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohortMatteo Piga, Alberto Floris, Gian Domenico Sebastiani, et al.
Clinical and Experimental Rheumatology|January 31, 2017
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based studyOlga Addimanda, Massimiliano Marino, Ilaria Farina, et al.
RMD Open|December 29, 2022
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational studyAlberto Floris, Elisabetta Chessa, Gian Domenico Sebastiani, et al.
Pageof 26